Renal function is a major predictor of circulating acyl-CoA-binding protein/diazepam-binding inhibitor

Authors:

Abstract
Objective: Acyl-CoA-binding protein (ACBP)/diazepam-binding inhibitor has lately been described as an endocrine factor affecting food intake and lipid metabolism. ACBP is dysregulated in catabolic/malnutrition states like sepsis or systemic inflammation. However, regulation of ACBP has not been investigated in conditions with impaired kidney function, so far.Design/methods: Serum ACBP concentrations were investigated by enzyme-linked immunosorbent assay i) in a cohort of 60 individuals with kidney failure (KF) on chronic haemodialysis and compared to 60 individuals with a preserved kidney function; and ii) in a human model of acute kidney dysfunction (AKD). In addition, mACBP mRNA expression was assessed in two CKD mouse models and in two distinct groups of non-CKD mice. Further, mRNA expression of mACBP was measured in vitro in isolated, differentiated mouse adipocytes - brown and white - after exposure to the uremic agent indoxyl sulfate.Results: Median [interquartile range] serum ACBP was almost 20-fold increased in KF (514.0 [339.3] µg/l) compared to subjects without KF (26.1 [39.1] µg/l) (pmACBP mRNA expression in different tissues of CKD mice in vivo or in indoxyl sulfate-treated adipocytes in vitro.Conclusions: Circulating ACBP inversely associates with renal function, most likely through renal retention of the cytokine. Future studies need to investigate ACBP physiology in malnutrition-related disease states, such as CKD, and to adjust for markers of renal function.
Funding Information
  • Deutsche Forschungsgemeinschaft (SFB 1052/3)
  • Deutsche Diabetes Gesellschaft (934300-002, Projektpreis der AG Diabetes und Niere 2020)
  • Novo Nordisk (Novo Nordisk postdoctoral fellowship run in partnership with Karolinska Institutet, Stockholm, Sweden)
  • Karolinska Institutet (Karolinska Institutet Research Foundation grant)
  • Stiftelsen Stig och Gunborg Westman (Research grant 2021)
  • Njurfonden (Research grant 2020)
  • European Foundation for the Study of Diabetes (EFSD Mentorship Programme supported by AstraZeneca)
  • Bundesministerium Bildung (FKZ 01EO1501, IFB Adiposity Diseases)
  • Medizinische Fakultät, Universität Leipzig (934100-012)
  • Freistaat Sachsen (ERA PerMed (Horizon 2020), PETictCAC" project (ERAPerMed_324))

This publication has 44 references indexed in Scilit: